Early research (Phase 1)Ended earlyNCT03530683
What this trial is testing
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
Who this might be right for
LymphomaMultiple MyelomaAcute Myeloid Leukemia+1 more
Pfizer 189